Dental products company Envista Holdings (NYSE:NVST) will be reporting results this Thursday after market close. Here’s what investors should know.
Envista beat analysts’ revenue expectations by 4.6% last quarter, reporting revenues of $669.9 million, up 11.5% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts’ constant currency revenue estimates and a solid beat of analysts’ revenue estimates.
Is Envista a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Envista’s revenue to grow 4% year on year to $678.7 million, improving from the 1.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.32 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Envista has missed Wall Street’s revenue estimates twice over the last two years.
Looking at Envista’s peers in the healthcare equipment and supplies segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Neogen’s revenues decreased 2.8% year on year, beating analysts’ expectations by 7.2%, and Intuitive Surgical reported revenues up 18.8%, topping estimates by 1%. Neogen traded up 30.4% following the results while Intuitive Surgical’s stock price was unchanged.
Read our full analysis of Neogen’s results here and Intuitive Surgical’s results here.
Investors in the healthcare equipment and supplies segment have had fairly steady hands going into earnings, with share prices down 1.7% on average over the last month. Envista is up 1.6% during the same time and is heading into earnings with an average analyst price target of $23.62 (compared to the current share price of $22.91).
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.